

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 5.69368753 |
| 2 | positive regulation of protein homodimerization activity (GO:0090073) | 5.08260174 |
| 3 | regulation of T cell chemotaxis (GO:0010819) | 4.92563043 |
| 4 | positive regulation of T cell chemotaxis (GO:0010820) | 4.92563043 |
| 5 | germinal center formation (GO:0002467) | 4.86409435 |
| 6 | T cell migration (GO:0072678) | 4.84971605 |
| 7 | cellular response to interleukin-15 (GO:0071350) | 4.74702480 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71889753 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.66335542 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61112928 |
| 11 | response to interleukin-15 (GO:0070672) | 4.60670915 |
| 12 | ribosome assembly (GO:0042255) | 4.52333877 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.42730503 |
| 14 | cellular response to arsenic-containing substance (GO:0071243) | 4.42303317 |
| 15 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.34207932 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33822519 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33814458 |
| 18 | negative regulation of cell killing (GO:0031342) | 4.33814458 |
| 19 | regulation of germinal center formation (GO:0002634) | 4.33753668 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28746314 |
| 21 | negative T cell selection (GO:0043383) | 4.26630862 |
| 22 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.21817887 |
| 23 | negative thymic T cell selection (GO:0045060) | 4.20546117 |
| 24 | segment specification (GO:0007379) | 4.18096756 |
| 25 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.14765271 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.09108936 |
| 27 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.08358992 |
| 28 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.07371702 |
| 29 | ncRNA catabolic process (GO:0034661) | 4.01517546 |
| 30 | tolerance induction (GO:0002507) | 3.98084692 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91809740 |
| 32 | definitive hemopoiesis (GO:0060216) | 3.90634407 |
| 33 | positive regulation of translational initiation (GO:0045948) | 3.85583658 |
| 34 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.85182642 |
| 35 | histone H3-K9 demethylation (GO:0033169) | 3.81294523 |
| 36 | regulation of sarcomere organization (GO:0060297) | 3.78052378 |
| 37 | stress granule assembly (GO:0034063) | 3.74091362 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66177603 |
| 39 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.61411890 |
| 40 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.61411890 |
| 41 | T cell differentiation involved in immune response (GO:0002292) | 3.61411890 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.61279131 |
| 43 | positive regulation of T cell migration (GO:2000406) | 3.60093274 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.58457235 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.50978098 |
| 46 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.50978098 |
| 47 | positive regulation of tolerance induction (GO:0002645) | 3.50818836 |
| 48 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.46829011 |
| 49 | response to vitamin E (GO:0033197) | 3.43723508 |
| 50 | positive regulation of granulocyte differentiation (GO:0030854) | 3.43238915 |
| 51 | defense response to protozoan (GO:0042832) | 3.40347653 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 3.40008615 |
| 53 | alpha-beta T cell differentiation (GO:0046632) | 3.39006875 |
| 54 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.38471707 |
| 55 | interferon-gamma production (GO:0032609) | 3.36572381 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.36030416 |
| 57 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.34892503 |
| 58 | T-helper cell differentiation (GO:0042093) | 3.34892503 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.34211301 |
| 60 | cytokine biosynthetic process (GO:0042089) | 3.34119651 |
| 61 | pentose-phosphate shunt (GO:0006098) | 3.33478774 |
| 62 | B cell homeostasis (GO:0001782) | 3.33111094 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31913203 |
| 64 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.29868752 |
| 65 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.29697060 |
| 66 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.26872314 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.26691503 |
| 68 | leukocyte aggregation (GO:0070486) | 3.25483098 |
| 69 | regulation of T cell migration (GO:2000404) | 3.24167103 |
| 70 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.22971161 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.22855079 |
| 72 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.21732928 |
| 73 | thymic T cell selection (GO:0045061) | 3.21281728 |
| 74 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14520975 |
| 75 | negative regulation of T cell mediated immunity (GO:0002710) | 3.13448885 |
| 76 | positive thymic T cell selection (GO:0045059) | 3.13038690 |
| 77 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.12983640 |
| 78 | positive regulation of lymphocyte migration (GO:2000403) | 3.12946197 |
| 79 | purine nucleobase metabolic process (GO:0006144) | 3.09605420 |
| 80 | face development (GO:0060324) | 3.08356736 |
| 81 | ubiquinone biosynthetic process (GO:0006744) | 3.07390783 |
| 82 | lymphocyte migration (GO:0072676) | 3.04662969 |
| 83 | positive regulation of cell killing (GO:0031343) | 3.04164114 |
| 84 | actin nucleation (GO:0045010) | 3.03548395 |
| 85 | heart field specification (GO:0003128) | 3.03129729 |
| 86 | secondary heart field specification (GO:0003139) | 3.03129729 |
| 87 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.02695015 |
| 88 | response to protozoan (GO:0001562) | 2.98629778 |
| 89 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.97484760 |
| 90 | positive T cell selection (GO:0043368) | 2.96597331 |
| 91 | T cell receptor signaling pathway (GO:0050852) | 2.96299398 |
| 92 | mitochondrion distribution (GO:0048311) | 2.95189447 |
| 93 | alpha-beta T cell activation (GO:0046631) | 2.92500626 |
| 94 | lymphocyte chemotaxis (GO:0048247) | 2.92317962 |
| 95 | T cell selection (GO:0045058) | 2.91530464 |
| 96 | cardiac ventricle formation (GO:0003211) | 2.91434274 |
| 97 | NADPH regeneration (GO:0006740) | 2.87973034 |
| 98 | regulation of cell killing (GO:0031341) | 2.86662818 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86335590 |
| 100 | cartilage morphogenesis (GO:0060536) | 2.84960795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.49233889 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.59853221 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.49641186 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.39643936 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.69427257 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64075402 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.53822608 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.51562317 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.43859941 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.26276264 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.14786468 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.14234557 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11958453 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86047970 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81541024 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.81478379 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.80194695 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.65141717 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.42554507 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.34628375 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.26324725 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21958705 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.15580068 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14610954 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 2.09722280 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95884408 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94152877 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92769037 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.90397559 |
| 30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.84588002 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80400597 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80273066 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76115666 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75201044 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66927336 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57304146 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52936116 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52469953 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51951487 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50385022 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44669063 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40101423 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39947792 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39476774 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38699292 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34229411 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34194244 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33860090 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29387089 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26651811 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21622812 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.20912398 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19390480 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15862543 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14967883 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13399267 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12740503 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11709826 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08411566 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08196029 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07707311 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00887214 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99657067 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98193461 |
| 65 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96327631 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95603333 |
| 67 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.94608107 |
| 68 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94381406 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93195755 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92019932 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91409443 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88663648 |
| 73 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88485735 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88109275 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87736047 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87648805 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85522907 |
| 78 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85102746 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84328886 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83813978 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83294339 |
| 82 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82996883 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81765672 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81255429 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79952997 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76197736 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75820945 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73722580 |
| 89 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71969469 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.71865680 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71774251 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.70668272 |
| 93 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.70267475 |
| 94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69818623 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69328641 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69012545 |
| 97 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67314320 |
| 98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.65664608 |
| 99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64940109 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64109025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.99767592 |
| 2 | MP0009333_abnormal_splenocyte_physiolog | 4.64385719 |
| 3 | MP0005671_abnormal_response_to | 4.13421040 |
| 4 | MP0002009_preneoplasia | 3.68638329 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.17284177 |
| 6 | MP0001873_stomach_inflammation | 3.01716108 |
| 7 | MP0008007_abnormal_cellular_replicative | 2.84267309 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.83275432 |
| 9 | MP0005387_immune_system_phenotype | 2.81540468 |
| 10 | MP0001790_abnormal_immune_system | 2.81540468 |
| 11 | MP0001800_abnormal_humoral_immune | 2.81284598 |
| 12 | MP0009785_altered_susceptibility_to | 2.62719314 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.51967176 |
| 14 | MP0000490_abnormal_crypts_of | 2.51023280 |
| 15 | MP0002405_respiratory_system_inflammati | 2.43466727 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.38810942 |
| 17 | MP0002723_abnormal_immune_serum | 2.30052651 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.29371734 |
| 19 | MP0003724_increased_susceptibility_to | 2.28680700 |
| 20 | MP0003436_decreased_susceptibility_to | 2.19700393 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.14324807 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.11701778 |
| 23 | MP0001819_abnormal_immune_cell | 2.09421815 |
| 24 | MP0005025_abnormal_response_to | 2.08077955 |
| 25 | MP0002006_tumorigenesis | 1.99926330 |
| 26 | MP0002398_abnormal_bone_marrow | 1.94731628 |
| 27 | MP0000703_abnormal_thymus_morphology | 1.93528061 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.93141903 |
| 29 | MP0006082_CNS_inflammation | 1.90584629 |
| 30 | MP0002419_abnormal_innate_immunity | 1.83964923 |
| 31 | MP0000685_abnormal_immune_system | 1.81501778 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.79642643 |
| 33 | MP0000716_abnormal_immune_system | 1.68683271 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.66165837 |
| 35 | MP0001849_ear_inflammation | 1.64102203 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.61154709 |
| 37 | MP0003329_amyloid_beta_deposits | 1.58923404 |
| 38 | MP0003866_abnormal_defecation | 1.53868738 |
| 39 | MP0004381_abnormal_hair_follicle | 1.50791588 |
| 40 | MP0002722_abnormal_immune_system | 1.49485337 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.45794964 |
| 42 | MP0000681_abnormal_thyroid_gland | 1.44000584 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.41351942 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.40489891 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.40306407 |
| 46 | MP0002933_joint_inflammation | 1.40216204 |
| 47 | MP0003045_fibrosis | 1.36623569 |
| 48 | MP0002429_abnormal_blood_cell | 1.36180285 |
| 49 | MP0008057_abnormal_DNA_replication | 1.36159063 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.36133724 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.35751804 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.32378942 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.30488009 |
| 54 | MP0000604_amyloidosis | 1.30420173 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.30112438 |
| 56 | MP0004947_skin_inflammation | 1.26297045 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.26088269 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.24396453 |
| 59 | MP0009278_abnormal_bone_marrow | 1.22972386 |
| 60 | MP0003448_altered_tumor_morphology | 1.10442815 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.08977125 |
| 62 | MP0009384_cardiac_valve_regurgitation | 1.06553669 |
| 63 | MP0004510_myositis | 1.05399098 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.02581110 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.01884920 |
| 66 | MP0005310_abnormal_salivary_gland | 1.00627532 |
| 67 | MP0001764_abnormal_homeostasis | 0.96102711 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 0.95417115 |
| 69 | MP0008469_abnormal_protein_level | 0.95113436 |
| 70 | MP0003303_peritoneal_inflammation | 0.94175854 |
| 71 | MP0005266_abnormal_metabolism | 0.87348627 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.87084396 |
| 73 | MP0001663_abnormal_digestive_system | 0.86572811 |
| 74 | MP0005670_abnormal_white_adipose | 0.84302558 |
| 75 | MP0005535_abnormal_body_temperature | 0.83767544 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.80532938 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.80348290 |
| 78 | MP0005166_decreased_susceptibility_to | 0.73752280 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.70298888 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.70298888 |
| 81 | MP0001851_eye_inflammation | 0.67864093 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.67085925 |
| 83 | MP0000371_diluted_coat_color | 0.65729302 |
| 84 | MP0000477_abnormal_intestine_morphology | 0.65447530 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.64983361 |
| 86 | MP0001502_abnormal_circadian_rhythm | 0.64719217 |
| 87 | MP0008569_lethality_at_weaning | 0.62993357 |
| 88 | MP0009764_decreased_sensitivity_to | 0.59500343 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.58394029 |
| 90 | MP0009115_abnormal_fat_cell | 0.56702357 |
| 91 | MP0008995_early_reproductive_senescence | 0.56561040 |
| 92 | MP0003690_abnormal_glial_cell | 0.56375953 |
| 93 | MP0004036_abnormal_muscle_relaxation | 0.56324380 |
| 94 | MP0002971_abnormal_brown_adipose | 0.55443975 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.52918307 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.51945215 |
| 97 | MP0002132_abnormal_respiratory_system | 0.51262540 |
| 98 | MP0001881_abnormal_mammary_gland | 0.50842467 |
| 99 | MP0003279_aneurysm | 0.50413382 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.49741233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.43625746 |
| 2 | Pustule (HP:0200039) | 5.14646527 |
| 3 | T lymphocytopenia (HP:0005403) | 4.80053210 |
| 4 | Reduced antithrombin III activity (HP:0001976) | 4.68291110 |
| 5 | Amniotic constriction ring (HP:0009775) | 4.35978501 |
| 6 | Abnormality of placental membranes (HP:0011409) | 4.35978501 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 4.32334432 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.32334432 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.30083933 |
| 10 | Cheilitis (HP:0100825) | 4.07784951 |
| 11 | Abnormality of the intrinsic pathway (HP:0010989) | 4.05052594 |
| 12 | J-shaped sella turcica (HP:0002680) | 3.85133853 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82157331 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 3.65901824 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.63086950 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.62585940 |
| 17 | IgG deficiency (HP:0004315) | 3.61026137 |
| 18 | Abnormality of T cells (HP:0002843) | 3.56774953 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 3.55175991 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.44401628 |
| 21 | Myositis (HP:0100614) | 3.42561109 |
| 22 | Increased IgM level (HP:0003496) | 3.42183872 |
| 23 | Volvulus (HP:0002580) | 3.41127614 |
| 24 | Encephalitis (HP:0002383) | 3.37658321 |
| 25 | Gingival bleeding (HP:0000225) | 3.37392446 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.36023629 |
| 27 | Optic neuritis (HP:0100653) | 3.36023629 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.33427150 |
| 29 | IgM deficiency (HP:0002850) | 3.22495848 |
| 30 | Orchitis (HP:0100796) | 3.17746115 |
| 31 | Chronic diarrhea (HP:0002028) | 3.11969434 |
| 32 | Hemoptysis (HP:0002105) | 3.02624356 |
| 33 | Abnormality of oral frenula (HP:0000190) | 3.01841344 |
| 34 | Meningitis (HP:0001287) | 2.91292619 |
| 35 | Eczematoid dermatitis (HP:0000976) | 2.90785921 |
| 36 | Combined immunodeficiency (HP:0005387) | 2.87643502 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87565205 |
| 38 | Absent/shortened dynein arms (HP:0200106) | 2.85678231 |
| 39 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.85678231 |
| 40 | Gingivitis (HP:0000230) | 2.81072040 |
| 41 | Rhabdomyolysis (HP:0003201) | 2.74183087 |
| 42 | Premature loss of primary teeth (HP:0006323) | 2.72842445 |
| 43 | Increased IgE level (HP:0003212) | 2.72798401 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.69241202 |
| 45 | Xerostomia (HP:0000217) | 2.68860020 |
| 46 | Abnormality of the prostate (HP:0008775) | 2.68202830 |
| 47 | Vasculitis (HP:0002633) | 2.65723763 |
| 48 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.64588795 |
| 49 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.64588795 |
| 50 | Abnormal protein glycosylation (HP:0012346) | 2.64588795 |
| 51 | Abnormal glycosylation (HP:0012345) | 2.64588795 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.63645348 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.59686363 |
| 54 | Obstructive lung disease (HP:0006536) | 2.58785214 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58785214 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.56481879 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.55427578 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.55178344 |
| 59 | Trismus (HP:0000211) | 2.53726484 |
| 60 | Recurrent skin infections (HP:0001581) | 2.51355341 |
| 61 | Abnormality of eosinophils (HP:0001879) | 2.49334696 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.49147247 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.45410736 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.44407894 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.44301993 |
| 66 | Chronic sinusitis (HP:0011109) | 2.43882691 |
| 67 | Chest pain (HP:0100749) | 2.41967391 |
| 68 | Broad face (HP:0000283) | 2.40603715 |
| 69 | Poikiloderma (HP:0001029) | 2.39068669 |
| 70 | Urticaria (HP:0001025) | 2.36304881 |
| 71 | Respiratory difficulties (HP:0002880) | 2.34791375 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.32288829 |
| 73 | Leukocytosis (HP:0001974) | 2.31098682 |
| 74 | Abnormality of the endocardium (HP:0004306) | 2.30606576 |
| 75 | Ankyloglossia (HP:0010296) | 2.30115036 |
| 76 | Gangrene (HP:0100758) | 2.29987834 |
| 77 | Thyroiditis (HP:0100646) | 2.29816337 |
| 78 | Biconcave vertebral bodies (HP:0004586) | 2.28958353 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.27173664 |
| 80 | Recurrent abscess formation (HP:0002722) | 2.25072866 |
| 81 | Cerebral palsy (HP:0100021) | 2.20957019 |
| 82 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.20698884 |
| 83 | Epistaxis (HP:0000421) | 2.20184386 |
| 84 | Periodontitis (HP:0000704) | 2.20158157 |
| 85 | Hypoproteinemia (HP:0003075) | 2.16131169 |
| 86 | Joint swelling (HP:0001386) | 2.15737698 |
| 87 | Recurrent viral infections (HP:0004429) | 2.15641393 |
| 88 | Abnormality of the preputium (HP:0100587) | 2.15115638 |
| 89 | Granulocytopenia (HP:0001913) | 2.12147609 |
| 90 | Pulmonary embolism (HP:0002204) | 2.10811393 |
| 91 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09229928 |
| 92 | Cervical subluxation (HP:0003308) | 2.08229391 |
| 93 | B lymphocytopenia (HP:0010976) | 2.06804925 |
| 94 | Spinal canal stenosis (HP:0003416) | 2.05863220 |
| 95 | Eosinophilia (HP:0001880) | 2.03146343 |
| 96 | Obstructive sleep apnea (HP:0002870) | 2.02554800 |
| 97 | Hyperlipoproteinemia (HP:0010980) | 2.02000767 |
| 98 | Recurrent bacterial skin infections (HP:0005406) | 2.00789893 |
| 99 | Ridged nail (HP:0001807) | 2.00684403 |
| 100 | Polyneuropathy (HP:0001271) | 1.97128874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.24417914 |
| 2 | TXK | 4.73874909 |
| 3 | MAP4K1 | 4.03550809 |
| 4 | GRK6 | 3.47397589 |
| 5 | ITK | 3.31838082 |
| 6 | CAMKK2 | 3.11747457 |
| 7 | SYK | 3.08247696 |
| 8 | FES | 2.84414942 |
| 9 | MAP3K13 | 2.81611285 |
| 10 | TNK2 | 2.59289295 |
| 11 | CSF1R | 2.37996163 |
| 12 | CDK3 | 2.19148656 |
| 13 | MAP3K14 | 2.17059190 |
| 14 | CSK | 2.12053027 |
| 15 | MAPK12 | 2.11703938 |
| 16 | CAMKK1 | 1.89118610 |
| 17 | MAPK7 | 1.79905746 |
| 18 | JAK3 | 1.75285262 |
| 19 | HCK | 1.72022988 |
| 20 | BTK | 1.69940328 |
| 21 | TYK2 | 1.69315999 |
| 22 | PASK | 1.68779631 |
| 23 | VRK1 | 1.59549922 |
| 24 | LCK | 1.56253513 |
| 25 | RIPK4 | 1.51916728 |
| 26 | KDR | 1.44847523 |
| 27 | TEC | 1.44102913 |
| 28 | KIT | 1.40151345 |
| 29 | NLK | 1.26409172 |
| 30 | IKBKE | 1.23277880 |
| 31 | PRKCQ | 1.19344128 |
| 32 | TAOK3 | 1.14464980 |
| 33 | IRAK2 | 1.14017836 |
| 34 | IRAK1 | 1.10846007 |
| 35 | IKBKB | 1.10436389 |
| 36 | ZAP70 | 1.06366722 |
| 37 | CAMK1D | 1.06351178 |
| 38 | PIK3CG | 1.05460654 |
| 39 | SIK3 | 1.00981654 |
| 40 | JAK1 | 1.00601222 |
| 41 | PIM1 | 0.93570267 |
| 42 | LYN | 0.93227643 |
| 43 | VRK2 | 0.89360155 |
| 44 | IGF1R | 0.88722489 |
| 45 | STK10 | 0.87050123 |
| 46 | MAP2K6 | 0.83745603 |
| 47 | JAK2 | 0.80069666 |
| 48 | BLK | 0.77325475 |
| 49 | NUAK1 | 0.71797288 |
| 50 | TBK1 | 0.67807251 |
| 51 | FYN | 0.67236099 |
| 52 | PRKCH | 0.66325553 |
| 53 | STK24 | 0.64806352 |
| 54 | YES1 | 0.63383680 |
| 55 | EIF2AK3 | 0.62763096 |
| 56 | TESK2 | 0.61949856 |
| 57 | MAP3K11 | 0.61945344 |
| 58 | NME2 | 0.59755275 |
| 59 | FGFR4 | 0.59176850 |
| 60 | MAP3K7 | 0.57207120 |
| 61 | TAOK2 | 0.56519879 |
| 62 | EPHB1 | 0.55110344 |
| 63 | MAP2K3 | 0.54728675 |
| 64 | IRAK4 | 0.51795959 |
| 65 | MARK3 | 0.50712780 |
| 66 | BRSK2 | 0.50645496 |
| 67 | PRKCD | 0.49142042 |
| 68 | CDK19 | 0.48042760 |
| 69 | ERN1 | 0.48030164 |
| 70 | TAOK1 | 0.47354056 |
| 71 | RPS6KB1 | 0.45453302 |
| 72 | PRPF4B | 0.45039053 |
| 73 | BMX | 0.44286468 |
| 74 | CAMK1G | 0.43987655 |
| 75 | ADRBK2 | 0.39721647 |
| 76 | LRRK2 | 0.35487876 |
| 77 | MAPKAPK3 | 0.34951389 |
| 78 | EPHA3 | 0.34846317 |
| 79 | GRK7 | 0.33692224 |
| 80 | MAP3K3 | 0.33252895 |
| 81 | GRK1 | 0.33243675 |
| 82 | CDK4 | 0.33156316 |
| 83 | ACVR1B | 0.32063275 |
| 84 | CAMK1 | 0.30572891 |
| 85 | PRKCE | 0.29915726 |
| 86 | MATK | 0.28954797 |
| 87 | TYRO3 | 0.27445976 |
| 88 | INSR | 0.26009979 |
| 89 | STK4 | 0.23578964 |
| 90 | PRKAA2 | 0.22452049 |
| 91 | EGFR | 0.22113703 |
| 92 | MAPKAPK2 | 0.21813790 |
| 93 | MAPK10 | 0.21046883 |
| 94 | PRKCA | 0.19993150 |
| 95 | CSNK2A1 | 0.19167860 |
| 96 | RAF1 | 0.18366449 |
| 97 | ATR | 0.16937815 |
| 98 | TGFBR2 | 0.16772133 |
| 99 | MAPK11 | 0.16155679 |
| 100 | PRKDC | 0.15275756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.52932206 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.06983708 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.77796499 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.56897364 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.54899127 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.54280518 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.51475188 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.82568008 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.44880846 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.41699077 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.05743314 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05568588 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.02486648 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94109731 |
| 15 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.74059455 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69228843 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66098340 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.63912584 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63547839 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57996438 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55849455 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.50771744 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41250895 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38262397 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37002340 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35063984 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32340206 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31672012 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.29143079 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23170590 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22270151 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20361385 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15165980 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11427000 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11384418 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10298395 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.05516488 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03908259 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01632586 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.00080503 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97381611 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96753281 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95872066 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95001763 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93215069 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 0.88909892 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.85293272 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80330356 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.80227595 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79437140 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78462274 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78038139 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.77727254 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76952536 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.76765560 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75817054 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75509066 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73174213 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69126573 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.68474083 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.67836476 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.60581269 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.58486992 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57024372 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55968404 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50381335 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46978417 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45504982 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44068841 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.42308375 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40222544 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38791784 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37723703 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37384793 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.30953867 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30325370 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.30314667 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29370756 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27288301 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.26280821 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.26230717 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25895897 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25631328 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25298151 |
| 85 | Spliceosome_Homo sapiens_hsa03040 | 0.24382256 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24016665 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23968585 |
| 88 | Ribosome_Homo sapiens_hsa03010 | 0.23041845 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.22621615 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20991406 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.19402210 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.18701888 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16954268 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.16217562 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.16071277 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15092958 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14200369 |
| 98 | Protein export_Homo sapiens_hsa03060 | 0.13515157 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.12747682 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10262034 |

